Shannon Ibabekci

Shannon Ibabekci has a diverse and extensive work experience in the clinical operations field. Shannon is currently working at Loxo Oncology at Lilly as the Executive Director of Clinical Operations, a position they have held since January 2023. Prior to that, they held various roles at Loxo Oncology at Lilly, including Associate Director, Clinical Operations, Director of Clinical Operations, Clinical Operations Trial Lead, Senior Clinical Trial Manager, and Clinical Trial Manager.

Before joining Loxo Oncology at Lilly, Shannon worked at PRA Health Sciences as a Project Manager II, where they managed global Phase II melanoma and Phase I Pediatric Non-CNS trials. Shannon was responsible for protocol feasibility, site selection, and the creation of study-level documents.

Additionally, Shannon worked at Covance as an Associate Project Manager, Study Start Up, where they tracked project progress and managed project plans and resources.

Shannon's earlier experience includes working at Roche Pharmaceuticals, where they held roles as a Country Senior Study Analyst, Clinical Operations Coordinator, and Clinical Sample Coordinator. In these roles, they contributed to various aspects of clinical trials, including regulatory documentation, site management, and sample coordination.

Overall, Shannon Ibabekci has a strong background in clinical operations, with experience in leadership positions and managing large-scale trials.

Shannon Ibabekci obtained a Bachelor of Arts degree in Business from Fairleigh Dickinson University.